Statins May Reduce Colorectal Cancer Risk

by VR Sreeraman on  October 19, 2010 at 1:27 PM Drug News   - G J E 4
Statins, cholesterol-lowering drugs used to prevent cardiac problems, are associated with reduced risk of colon and rectal cancers, says a new research. comprehensive analysis by researchers at the University of Michigan at Ann Arbor included 22 scientific studies with more than 2.5 million combined participants.
 Statins May Reduce Colorectal Cancer Risk
Statins May Reduce Colorectal Cancer Risk

"Statin use was associated with a statistically significant reduction in colorectal cancer," explained Jewel Samadder.

The relative risk was 0.88 and represents a 12pc reduction in the odds of colorectal cancer among statin users. This effect was largely consistent across study design with both case control and cohort studies showing a strong correlation.

The length of statin use, both greater than 6 months and greater than 5 years of use was associated with reduction in colorectal cancer risk. Importantly, when the analysis was stratified for statin type, the most common category of statins, lipophilic (which includes atorvastatin or Lipitor), showed the greatest effect.

"Observational studies have suggested that long term use of statins is associated with reduced risk of several cancers, including breast, prostate, lung, pancreas and liver. Our findings suggest that randomized controlled trials designed to test the hypothesis that statins reduce the risk of colorectal cancer are warranted," added Dr. Samadder.

Source: ANI

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like